http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100342336-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ae96c0ecc22ff90ff986371a3cea0f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-453 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02 |
| filingDate | 2000-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1318ccf7059c92a90599efda4b2dcd0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_189a2c0adce448ba7810f2446af6f75e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8084044e4c8553fd3d8a9a0c33a26cfb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0f196da47cf96fc300712286c23b77c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c514af567ef59def074e7f0b1013c29 |
| publicationDate | 2002-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100342336-B1 |
| titleOfInvention | A pharmaceutical composition comprising β-alanine derivative |
| abstract | The present invention relates to glycoprotein IIb / IIIa antagonists, platelet aggregation inhibitors, and inhibitors of binding of fibrinogen to platelets, the following formula (1) and pharmaceutically acceptable salts thereof, methods for preparing the same, and pharmaceutical compositions comprising the same and specifications in humans or animals It relates to a method for preventing and / or treating a disease described in the following.n n n Formula 1n n n n n n n n In the above formula,n n n R 1 is an N-containing cycloalkyl which may have one or more suitable substituent (s),n n n R 2 is carboxy or protected carboxy,n n n A 1 is lower alkylene, lower alkanyl-ylidene or lower alkenylene, which may each have one or more suitable substituent (s),n n n A 2 is lower alkylene,n n n A 3 is lower alkylene which may have one or more suitable substituent (s),n n n Silver expression (here, Is an N-containing heterocyclic group which may have one or more suitable substituent (s),n n n X is O, S or NH,n n n Y is NH,n n n Z is , or (Wherein R 3 is hydrogen or lower alkyl),n n n l, m and n are the same or different and are integers equal to 0 or 1, respectively. |
| priorityDate | 1994-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 632.